MXPA05003279A - Modified release dosage form with two cores. - Google Patents
Modified release dosage form with two cores.Info
- Publication number
- MXPA05003279A MXPA05003279A MXPA05003279A MXPA05003279A MXPA05003279A MX PA05003279 A MXPA05003279 A MX PA05003279A MX PA05003279 A MXPA05003279 A MX PA05003279A MX PA05003279 A MXPA05003279 A MX PA05003279A MX PA05003279 A MXPA05003279 A MX PA05003279A
- Authority
- MX
- Mexico
- Prior art keywords
- dosage form
- cores
- release dosage
- modified release
- core
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
The invention provides a dosage form comprising at least one active ingredient, and first core and second cores surrounded by and separated by a shell. The dosage form provides a delay of at least one hour between the initial release of active ingredient contained in said first core and the initial release of active ingredient contained in said second core after contacting of the dosage form with a liquid medium.
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2002/031117 WO2003026629A2 (en) | 2001-09-28 | 2002-09-28 | Modified release dosage forms |
| PCT/US2002/031062 WO2003026626A2 (en) | 2001-09-28 | 2002-09-28 | Modified release dosage forms |
| PCT/US2002/031129 WO2003026630A1 (en) | 2001-09-28 | 2002-09-28 | Dosage forms having an inner core and outer shell with different shapes |
| PCT/US2002/031163 WO2003026627A1 (en) | 2001-09-28 | 2002-09-28 | Composite dosage forms |
| PCT/US2002/031024 WO2003026625A1 (en) | 2001-09-28 | 2002-09-28 | Modified release dosage forms |
| PCT/US2003/008859 WO2004028512A1 (en) | 2002-09-28 | 2003-03-21 | Modified release dosage form with two cores |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA05003279A true MXPA05003279A (en) | 2005-11-23 |
Family
ID=35276283
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA05003279A MXPA05003279A (en) | 2002-09-28 | 2003-03-21 | Modified release dosage form with two cores. |
| MXPA05003281A MXPA05003281A (en) | 2002-09-28 | 2003-03-21 | Modified release dosage forms with two cores and an opening. |
| MXPA05003282A MXPA05003282A (en) | 2002-09-28 | 2003-03-21 | Immediate release dosage form comprising shell having openings therein. |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA05003281A MXPA05003281A (en) | 2002-09-28 | 2003-03-21 | Modified release dosage forms with two cores and an opening. |
| MXPA05003282A MXPA05003282A (en) | 2002-09-28 | 2003-03-21 | Immediate release dosage form comprising shell having openings therein. |
Country Status (2)
| Country | Link |
|---|---|
| MX (3) | MXPA05003279A (en) |
| NO (2) | NO20052037L (en) |
-
2003
- 2003-03-21 MX MXPA05003279A patent/MXPA05003279A/en unknown
- 2003-03-21 MX MXPA05003281A patent/MXPA05003281A/en active IP Right Grant
- 2003-03-21 MX MXPA05003282A patent/MXPA05003282A/en not_active Application Discontinuation
-
2005
- 2005-04-26 NO NO20052037A patent/NO20052037L/en not_active Application Discontinuation
- 2005-04-26 NO NO20052036A patent/NO20052036L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA05003281A (en) | 2005-11-23 |
| NO20052036L (en) | 2005-06-22 |
| MXPA05003282A (en) | 2005-11-23 |
| NO20052037L (en) | 2005-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2004056337A3 (en) | Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats | |
| WO2002053128A3 (en) | Sustained release drug delivery devices with multiple agents | |
| WO2003026626A3 (en) | Modified release dosage forms | |
| WO2003028660A3 (en) | Drug delivery devices and methods | |
| WO2004064769A3 (en) | Methods for making and using topical delivery agents | |
| HK1049630A1 (en) | Highly selective norepinephrine reuptake inhibitors and methods of using the same. | |
| ZA200301813B (en) | Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them. | |
| GEP20105083B (en) | A solid pharmaceutical dosage formulation | |
| PL362690A1 (en) | Combinations of drugs (e.g., chlorpromazine and pentamidine) for the treatment of neoplastic disorders | |
| WO2002056863A3 (en) | Sustained release drug delivery devices | |
| MA26800A1 (en) | AEROSOL SYSTEMS AND METHODS FOR PHARMACEUTICAL FORMULATIONS. | |
| HK1037032A1 (en) | Powder container, the assembly method thereof and the method for reducing the capacity of the container. | |
| WO2007028512A3 (en) | Magnetic-field controlled active substance transfer for aerosol therapy | |
| WO2004028504A8 (en) | Modified release dosage forms | |
| WO2005007137A8 (en) | Tablets containing ambroxol | |
| MXPA04005282A (en) | Wrapped absorbent structure. | |
| AU2001249393A1 (en) | Pharmaceutical comprising an agent that blocks the cell cycle and an antibody | |
| WO2005009410A3 (en) | Pharmaceutical compositions having a swellable coating | |
| WO2005105081A3 (en) | Therapeutic formulations of desoxyepothilones | |
| BR0314787A (en) | Modified Release Dosage Form | |
| AU2002343727A1 (en) | Tampon with non-aggressive, fluid wicking overwrap | |
| WO2002034240A3 (en) | Delayed and sustained release formulations and method of use thereof | |
| ZA200304928B (en) | Medicament containing a polyamine as an active substance. | |
| NO20034524D0 (en) | 5-membered heterocycles, preparation and use thereof as MAO inhibitors and lipid peroxidation inhibitors, preparation thereof and use thereof as drugs. | |
| MXPA05003279A (en) | Modified release dosage form with two cores. |